Navigation Links
Smith Medical Partners Announces Logistics Agreement for Cardium's National Distribution of Excellagen™
Date:4/2/2012

WOOD DALE, Ill., April 2, 2012 /PRNewswire/ -- Smith Medical Partners, the specialty pharmaceutical subsidiary of H. D. Smith, today announced an exclusive logistics and cold chain services agreement with Cardium Therapeutics (NYSE Amex: CXM), a health sciences and regenerative medicine company, to support its recently launched wound care product, Excellagen™.  Excellagen is a professional-use, syringe-based wound care product used in the management of diabetic foot ulcers, pressure ulcers and other dermal wounds. 

"The secure and efficient distribution of specialty pharmaceutical products is a critical and growing need for the U.S. healthcare system – particularly because so many innovative medicines require specialized handling and dispensing," stated Dave DuRoss, president, Smith Medical Partners.  "Combining our logistics expertise with the manufacturing capabilities of leaders such as Cardium enables us to support the launch and distribution of specialty products that impact patient care, like Excellagen."

The U.S. Centers for Disease Control and Prevention (CDC) estimates that approximately 26 million people in the United States had diabetes in 2010(1). Diabetic foot ulcers, a major complication of diabetes, occur in 15 percent of diabetes patients and precede 84 percent of all lower leg amputations(2).  H. D. Smith and Smith Medical Partners are well positioned to provide distribution and specialized services along the entire specialty pharmaceutical supply chain – from the manufacturer to the patient. 

"As a growing segment of H. D. Smith's business, Smith Medical Partners seeks to be a leader in the specialty marketplace, offering a full-service model of support for manufacturers and customers – from bench to bedside," said Dale Smith, H. D. Smith Chief Executive Officer.  "The partnership with Cardium is the latest reflection of our ongoing commitment to patients across the country – ensuring that the healthcare providers and local pharmacies they depend on have the medicines they need, when they're needed.  We are pleased to work alongside Cardium in this critical mission to deliver medical advances for patients."

About Smith Medical Partners
As a wholly owned subsidiary of H. D. Smith, Smith Medical Partners focuses on specialty pharmaceutical distribution and services.  Smith Medical Partners delivers to healthcare providers lifesaving medicines and supplies, including a full line of brand pharmaceuticals, injectables, vaccines and a robust generics portfolio.  Licensed in all 50 states, Smith Medical Partners combines national reach with accessibility.  With a knowledgeable team focused on providing exceptional customer care and offering valuable insight on item selection, patient assistance programs and reimbursement solutions, Smith Medical Partners services hundreds of specialty pharmacies and thousands of physician offices and clinics of all sizes.  More than just product dispersal, Smith Medical Partners provides flexible offerings that facilitate cost-containment and efficiency throughout the supply chain, including helping manufacturers procure credentialed comparator products for clinical trials, third-party logistics and back-end telesales support for new and end of life cycle commercial products. 

Additional information about Smith Medical Partners can be found at smpspecialty.com.

(1) http://www.cdc.gov/media/releases/2011/p0126_diabetes.html
(2) Brem H, Tomic-Canic M.  Cellular and molecular basis of wound healing in diabetes.  J Clin Invest.  2007; 117(5): 1219-1222.  doi:10.1172/JCI32169.Tom Doyle

Mark MarmurSmith Medical Partners

Makovsky + Company, Inc.Vice President New Buisness Development

Assistant Vice President715.338.4518

212.508.9670tom.doyle@smpspecialty.com  

mmarmur@makovsky.com  


'/>"/>
SOURCE Smith Medical Partners
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
2. GlaxoSmithKline Accelerates Review of Exelixis XL880
3. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
4. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
5. GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program
6. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
7. SpineSmith Partners to Present at 3rd Annual Stem Cell Summit
8. GlaxoSmithKline Reports Further Progress of Oncology Portfolio
9. GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant)
10. GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers
11. GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... LONDON , Dec. 6, 2016 Diabetes ... The diabetes and obesity disease cluster is currently ... (T1DM) and type 2 diabetes mellitus (T2DM), and the ... and quality of products, is attributable to these indications. ... a large market presence, there are a large number ...
(Date:12/6/2016)... 6, 2016 The pen needles market is ... USD 1.65 billion in 2016, growing at a CAGR ... 2021. Over the years, the pen needles market ... to the growing demand for safety injections in the ... of safety pen needles with an aim to reduce ...
(Date:12/6/2016)... Eurofins Genomics today announced it has ... American Pathologists (CAP) and certification under the Clinical ... in Louisville, KY , where ... "Our new CLIA-licensed and CAP-accredited clinical ... considered the ,Gold Standard, method for validation of ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... ... Business Brilliance Awards under the Best New Product Launch category. Gensuite’s entry on ... user experience. , BOC Global Events & Training Group is a professional event ...
(Date:12/7/2016)... ... December 07, 2016 , ... Maureen ... Program at Reproductive Medicine Associates of Connecticut (RMACT). McLaughlin brings nearly 20 years ... three acupuncturists to help patients realize their family building goals. Acupuncture helps ...
(Date:12/7/2016)... ... December 07, 2016 , ... “Tomorrow Trump Goes To Washington”: ... greatness back to the presidency and to America. “Tomorrow Trump Goes To Washington” is ... much as she can for this country. , Nancy attributes her patriotic nature to ...
(Date:12/7/2016)... ... ... Rides a Train” allows readers to tag along on a special shopping trip for ... creation of published author, Janet Morrison, who has been writing mostly poetry, essays, professional ... series is her first attempt at writing for children. Janet, Fred, and two cats ...
(Date:12/7/2016)... ... December 07, 2016 , ... The ... Innovation Summit in Reston, VA on March 21-22, 2017. This premier event features ... of experiences from a cross-section of industries such as financial services, insurance, healthcare, ...
Breaking Medicine News(10 mins):